The Boston biomedical cluster includes 1000+ companies and is supported by research at leading universities and academic research centers; Kendall Square alone is home to more than 120 life science companies.
The sector has been encouraged through the investment of private and public capital, including the $1B commitment of the 2008 Massachusetts Life Sciences Act. Keep up with every development: Subscribe FREE to Big4Bio:Boston.
Subscribe
LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]
